TY - JOUR
T1 - External validation and updating of prediction models for estimating the 1-year risk of low health-related quality of life in colorectal cancer survivors
AU - Révész, Dóra
AU - van Kuijk, Sander M J
AU - Mols, Floortje
AU - van Duijnhoven, Fränzel J B
AU - Winkels, Renate M
AU - Kant, IJmert
AU - van den Brandt, Piet A
AU - Smits, Luc J
AU - Breukink, Stéphanie O
AU - Kampman, Ellen
AU - Beijer, Sandra
AU - Weijenberg, Matty P
AU - Bours, Martijn J L
N1 - Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2022/12
Y1 - 2022/12
N2 - OBJECTIVE: Timely identification of colorectal cancer (CRC) survivors at risk of experiencing low health-related quality of life (HRQoL) in the near future is important for enabling appropriately tailored preventive actions. We previously developed and internally validated risk prediction models to estimate 1-year risk of low HRQoL in long-term CRC survivors. In this article, we aim to externally validate and update these models in a population of short-term CRC survivors.STUDY DESIGN AND SETTING: In a pooled cohort of 1,596 CRC survivors, seven HRQoL domains (global QoL, cognitive/emotional/physical/role/social functioning, fatigue) were measured prospectively at ∼5 months post-diagnosis (baseline for prediction) and ∼1 year later by a validated patient-reported outcome measure (EORTC QLQ-C30). For each HRQoL domain, 1-year scores were dichotomized into low versus normal/high HRQoL. Performance of the previously developed multivariable logistic prediction models was evaluated (calibration, discrimination). Models were updated to create a more parsimonious predictor set for all HRQoL domains.RESULTS: Updated models showed good calibration and discrimination (AUC≥0.75), containing a single set of 15 predictors, including non-modifiable (age, sex, education, time since diagnosis, chemotherapy, radiotherapy, stoma, comorbidities) and modifiable predictors (body mass index, physical activity, smoking, anxiety/depression, and baseline fatigue and HRQoL domain scores).CONCLUSION: Externally validated and updated prediction models performed well for estimating 1-year risk of low HRQoL in CRC survivors within 6 months post-diagnosis. The impact of implementing the models in oncology practice to improve HRQoL outcomes in CRC survivors needs to be evaluated.
AB - OBJECTIVE: Timely identification of colorectal cancer (CRC) survivors at risk of experiencing low health-related quality of life (HRQoL) in the near future is important for enabling appropriately tailored preventive actions. We previously developed and internally validated risk prediction models to estimate 1-year risk of low HRQoL in long-term CRC survivors. In this article, we aim to externally validate and update these models in a population of short-term CRC survivors.STUDY DESIGN AND SETTING: In a pooled cohort of 1,596 CRC survivors, seven HRQoL domains (global QoL, cognitive/emotional/physical/role/social functioning, fatigue) were measured prospectively at ∼5 months post-diagnosis (baseline for prediction) and ∼1 year later by a validated patient-reported outcome measure (EORTC QLQ-C30). For each HRQoL domain, 1-year scores were dichotomized into low versus normal/high HRQoL. Performance of the previously developed multivariable logistic prediction models was evaluated (calibration, discrimination). Models were updated to create a more parsimonious predictor set for all HRQoL domains.RESULTS: Updated models showed good calibration and discrimination (AUC≥0.75), containing a single set of 15 predictors, including non-modifiable (age, sex, education, time since diagnosis, chemotherapy, radiotherapy, stoma, comorbidities) and modifiable predictors (body mass index, physical activity, smoking, anxiety/depression, and baseline fatigue and HRQoL domain scores).CONCLUSION: Externally validated and updated prediction models performed well for estimating 1-year risk of low HRQoL in CRC survivors within 6 months post-diagnosis. The impact of implementing the models in oncology practice to improve HRQoL outcomes in CRC survivors needs to be evaluated.
U2 - 10.1016/j.jclinepi.2022.09.019
DO - 10.1016/j.jclinepi.2022.09.019
M3 - Article
C2 - 36220623
SN - 0895-4356
VL - 152
SP - 127
EP - 139
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
ER -